CLASS I Drug recall · Reported 19 Sep 2018 · FDA Enforcement Report

Neuroveen, Homeopathic recalled by Hellolife

Hellolife is recalling Neuroveen, Homeopathic (, distributed nationwide in the US. The recall was initiated on 23 Aug 2018 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesLot: NV/030717D, exp 7/2019

Quantity recalled4,358 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number: D-1201-2018
FDA event ID: 80893
Recalling firm: Hellolife, Grand Rapids, MI
Classification: Class I
Status: Terminated
Recall initiated: 23 Aug 2018
FDA classified: 17 Sep 2018
Reported: 19 Sep 2018
Type: Voluntary: Firm initiated
Customers notified by: Letter
Reason category: Other Bacterial Contamination

Timeline

23 Aug 2018	Recall initiated by company
17 Sep 2018	Classified by FDA	+25 days
19 Sep 2018	Published in enforcement report	+2 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Microbial Contamination of Non Sterile Products; Products contaminated with microoganisms, including but not limited to Staphylococcus saprophyticus and Burkholderia cepacia

Product as listed by the FDA

Neuroveen, Homeopathic (OTC Medicine), 2 fl oz (59 mL) per bottle, Mftd for: HelloLife, Inc. 4635 40th St SE, Grand Rapids, MI 49512. NDC: 49726-015-02

Where it was distributed

Nationwide USA, Algeria Australia Belgium Brazil Bulgaria Canada Colombia Croatia Cyprus Czech Republic Denmark Dominican Republic Ecuador Estonia French Polynesia Greece Guadeloupe Guam Hong Kong Hungary India Ireland Israel Italy Latvia Lithuania Martinique Mexico Monaco Netherlands New Zealand Norway Peru Poland Portugal Romania Russia Russian Federation Saudi Arabia Senegal Serbia Slovakia Slovakia (Slovak Republic) Slovenia Swaziland Sweden Switzerland Taiwan Turkey United Kingdom

Nationwide

Questions about this recall

Why was it recalled?

Microbial Contamination of Non Sterile Products; Products contaminated with microoganisms, including but not limited to Staphylococcus saprophyticus and Burkholderia cepacia

Which lots are affected?

Lot: NV/030717D, exp 7/2019

Where was it sold?

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

3 other products · FDA event 80893

This product is part of a recall event; the main page for the event is Respitrol, Homeopathic recalled by Hellolife.

Reported	Class	Recall	Company	Reason	Where
19 Sep 2018	CLASS I	Respitrol, Homeopathic recalled by Hellolife	Hellolife	Other Bacterial Contamination	Nationwide
19 Sep 2018	CLASS I	Compulsin, Homeopathic recalled by Hellolife	Hellolife	Other Bacterial Contamination	Nationwide
19 Sep 2018	CLASS I	Thyroveev, Homeopathic recalled by Hellolife	Hellolife	Other Bacterial Contamination	Nationwide

More recalls from Hellolife

All 4

Reported	Class	Recall	Company	Reason	Where
19 Sep 2018Drug	CLASS I	Thyroveev, Homeopathic recalled by Hellolife	Hellolife	Other Bacterial Contamination	Nationwide
19 Sep 2018Drug	CLASS I	Compulsin, Homeopathic recalled by Hellolife	Hellolife	Other Bacterial Contamination	Nationwide
19 Sep 2018Drug	CLASS I	Respitrol, Homeopathic recalled by Hellolife	Hellolife	Other Bacterial Contamination	Nationwide